Literature DB >> 22664942

The epidemiology of drug recalls in the United States.

Bo Wang, Joshua J Gagne, Niteesh K Choudhry.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22664942     DOI： 10.1001/archinternmed.2012.2013

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  8 in total

1.  Product safety spillovers and market viability for biologic drugs.

Authors:  John Romley; Tiffany Shih
Journal:  Int J Health Econ Manag       Date:  2016-12-23

Review 2.  Fungi associated with drug recalls and rare disease outbreaks.

Authors:  Donald G Ahearn; R Doyle Stulting
Journal:  J Ind Microbiol Biotechnol       Date:  2014-08-31       Impact factor: 3.346

3.  Illicit Internet availability of drugs subject to recall and patient safety consequences.

Authors:  Tim K Mackey; Phyo Aung; Bryan A Liang
Journal:  Int J Clin Pharm       Date:  2015-07-07

4.  Variations in Patients' Perceptions and Use of Generic Drugs: Results of a National Survey.

Authors:  Aaron S Kesselheim; Joshua J Gagne; Jessica M Franklin; Wesley Eddings; Lisa A Fulchino; Jerry Avorn; Eric G Campbell
Journal:  J Gen Intern Med       Date:  2016-02-16       Impact factor: 5.128

5.  Leveraging electronic health records to notify pediatric patients of a drug recall.

Authors:  Michael M Mendelson; Justin P Zachariah; Sarah D de Ferranti; Jonathan P Bickel
Journal:  JAMA Pediatr       Date:  2013-12       Impact factor: 16.193

6.  [Market surveillance and control of substandard, falsified and unregistered medicines: integrative reviewVigilancia y control de medicamentos subestándar, falsificados y no registrados: una revisión integral].

Authors:  Mary Anne Fontenele Martins; Magda Duarte Dos Anjos Scherer; Geraldo Lucchese
Journal:  Rev Panam Salud Publica       Date:  2022-05-03

7.  Paying physicians to prescribe generic drugs and follow-on biologics in the United States.

Authors:  Ameet Sarpatwari; Niteesh K Choudhry; Jerry Avorn; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2015-03-17       Impact factor: 11.069

8.  Drugs and Devices: Comparison of European and U.S. Approval Processes.

Authors:  Gail A Van Norman
Journal:  JACC Basic Transl Sci       Date:  2016-08-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.